Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Adma Biologics: Q4 Earnings Snapshot
Adma Biologics: Q4 Earnings Snapshot
Associated Press Finance
Thu, February 26, 2026 at 6:45 AM GMT+9 1 min read
In this article:
ADMA
+1.03%
RAMSEY, N.J. (AP) — RAMSEY, N.J. (AP) — Adma Biologics Inc. (ADMA) on Wednesday reported fourth-quarter earnings of $49.4 million.
On a per-share basis, the Ramsey, New Jersey-based company said it had net income of 20 cents.
The infectious disease drug developer posted revenue of $139.2 million in the period.
For the year, the company reported profit of $146.9 million, or 60 cents per share. Revenue was reported as $510.2 million.
Adma Biologics expects full-year revenue of $635 million.
Adma Biologics shares have dropped 14% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $15.68, a rise of nearly 2% in the last 12 months.
This story was generated by Automated Insights () using data from Zacks Investment Research. Access a Zacks stock report on ADMA at
Terms and Privacy Policy
Privacy Dashboard
More Info